A comparison of the effects and complications of transforaminal Triamcinolone and Dexmedetomidine in radicular low back pain.

Phase 3

Recruiting

• Conditions: chronic low back pain.; low back pain

• Registration Number: IRCT201312037984N12
• Lead Sponsor: Vice Chancellor for Research and Technology of Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Inclusion criteriaAge 20-70 years; Pain that has not responded to treatment for at least 6 weeks; Evidence of Nerve root involvement as disc bulging and/or foraminal stenosis in CT/MRI; VAS > 4; ASA class I, II; Patients’ Informed consent
Exclusion criteria: Patients with coagulopathy ; Infection in injection site as Herpetic diseases; Anatomical and congenital spine deformity as severe scoliosis; Surgical history instrument insertion; Psychological severe disorders; History of harmful reaction to local anesthetic and steroid; Patients with motor deficit or progressive neural defect; Cancer ; Neural foramen radiological access difficulty; Substance abuse; HIV; Acute trauma; Cauda Equina syndrome; More than 3 level abnormalities ;.Absence of radicular pain

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ow back pain. Timepoint: Before injection,two weeks,1,3 and 6 month after intervention. Method of measurement: pain score measured with visual analogue scale in Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Oswestry Disability Index questionnaire (ODI) and straight leg raising test (SLR), complications. Timepoint: Before injection, two weeks, 1,3 and 6 moth after intervention. Method of measurement: Questionnaire.